177 related articles for article (PubMed ID: 23004352)
1. Incidence and survival patterns of cutaneous T-cell lymphomas in the United States.
Imam MH; Shenoy PJ; Flowers CR; Phillips A; Lechowicz MJ
Leuk Lymphoma; 2013 Apr; 54(4):752-9. PubMed ID: 23004352
[TBL] [Abstract][Full Text] [Related]
2. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
Amber KT; Bloom R; Nouri K
Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
[TBL] [Abstract][Full Text] [Related]
3. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous lymphomas: a population-based descriptive study of 71 consecutive cases diagnosed between 1980 and 2003.
Riou-Gotta MO; Fournier E; Mermet I; Pelletier F; Humbert P; Danzon A; Aubin F
Leuk Lymphoma; 2008 Aug; 49(8):1537-44. PubMed ID: 18766967
[TBL] [Abstract][Full Text] [Related]
5. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
Criscione VD; Weinstock MA
Arch Dermatol; 2007 Jul; 143(7):854-9. PubMed ID: 17638728
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases.
Bradford PT; Devesa SS; Anderson WF; Toro JR
Blood; 2009 May; 113(21):5064-73. PubMed ID: 19279331
[TBL] [Abstract][Full Text] [Related]
7. Age, race, sex, stage, and incidence of cutaneous lymphoma.
Wilson LD; Hinds GA; Yu JB
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):291-6. PubMed ID: 23040434
[TBL] [Abstract][Full Text] [Related]
8. Changing incidence trends of cutaneous T-cell lymphoma.
Korgavkar K; Xiong M; Weinstock M
JAMA Dermatol; 2013 Nov; 149(11):1295-9. PubMed ID: 24005876
[TBL] [Abstract][Full Text] [Related]
9. Incidence of primary cutaneous T-cell lymphoma in Norway.
Saunes M; Nilsen TI; Johannesen TB
Br J Dermatol; 2009 Feb; 160(2):376-9. PubMed ID: 18808419
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and severity of pruritus in cutaneous T cell lymphoma.
Vij A; Duvic M
Int J Dermatol; 2012 Aug; 51(8):930-4. PubMed ID: 22788808
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV
Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286
[TBL] [Abstract][Full Text] [Related]
12. Racial Disparities in Mycosis Fungoides/Sézary Syndrome-A Single-Center Observational Study of 292 Patients.
Gandham AR; Geller S; Dusza SW; Kupper TS; Myskowski PL
Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e174-e180. PubMed ID: 38245472
[TBL] [Abstract][Full Text] [Related]
13. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
14. Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study.
Maurelli M; Tessari G; Colato C; Schena D; Girolomoni G
Eur J Dermatol; 2018 Feb; 28(1):44-49. PubMed ID: 29171395
[TBL] [Abstract][Full Text] [Related]
15. Mycosis fungoides and Sézary syndrome in Japan. Clinicopathologic study of 107 autopsy cases.
Arai E; Katayama I; Ishihara K
Pathol Res Pract; 1991 May; 187(4):451-7. PubMed ID: 1876527
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R
J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828
[TBL] [Abstract][Full Text] [Related]
19. Frequency of primary cutaneous lymphoma variants in Austria: retrospective data from a dermatology referral centre between 2006 and 2013.
Eder J; Kern A; Moser J; Kitzwögerer M; Sedivy R; Trautinger F
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1517-23. PubMed ID: 25600184
[TBL] [Abstract][Full Text] [Related]
20. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
